Google Ad

Coronavirus boosts gross sales for French pharma big Sanofi

The coronavirus pandemic has boosted the revenue of French pharma big Sanofi

French pharmaceutical big Sanofi stated Friday that its first quarter gross sales surged partly because of stockpiling of the painkiller Doliprane, as different firms around the globe battle throughout the coronavirus pandemic.

Sales of Doliprane—paracetamol which might alleviate the fever and aches related to the virus—shot up by greater than 20 p.c, serving to increase the agency’s internet gross sales by 6.9 p.c to almost 9 billion euros ($9.6 billion).

“COVID-19 stocking in channels explains about half of company sales growth in Q1,” the corporate stated in a press release.

The firm additionally credited gross sales of Dupixent, a therapy for atopic dermatitis and bronchial asthma, which soared by practically 130 p.c.

Sanofi stated its internet revenue grew by 15.9 p.c over the primary three months of 2020, with “roughly half of this growth due to COVID-19 impact.”

The Paris-based pharma big has additionally began collaborations to work on a coronavirus vaccine that’s hoped will enter medical trials this 12 months, probably making it obtainable within the second half of 2021.

Meanwhile, it has launched two research into whether or not hydroxychloroquine, a drug for rheumatoid arthritis and lupus which Sanofi sells below the model title Plaquenil, will be an efficient therapy for coronavirus sufferers.

More than 190,000 folks have died—together with virtually 22,000 in France—and practically 2,700,000 been contaminated because the virus emerged in China in December.


Sanofi affords 100 mln doses of hydroxychloroquine in COVID-19 struggle


© 2020 AFP

Citation:
Coronavirus boosts gross sales for French pharma big Sanofi (2020, April 24)
retrieved 11 May 2020
from https://medicalxpress.com/information/2020-04-coronavirus-boosts-sales-french-pharma.html

This doc is topic to copyright. Apart from any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.

Latest Updates

Related Post